4+ hour, 42+ min ago  (321+ words) Boehringer Ingelheim has launched a dedicated artificial intelligence (AI) and machine learning (ML) centre in London, marking a key expansion of its global computational research network focused on drug discovery and patient outcomes. The new site, located in King's Cross, is…...

3+ mon, 1+ week ago  (375+ words) Variant Bio, a private biotech firm, has launched an artificial intelligence-powered platform that uses genetic data to discover new drug candidates for potential entry into human trials. The platform, called Inference, applies artificial intelligence to analyze proprietary and public human…...